Morgan Chandler

Ms. Morgan Chandler


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2019 in ACS Nano
Verified
Journal Article
Closed access
MPMartin Panigaj
Martin Panigaj
MJM. Brittany Johnson
M. Brittany Johnson
WKWeina Ke
Weina Ke
JMJessica McMillan
Jessica McMillan
EGEkaterina A. Goncharova
Ekaterina A. Goncharova
KAKirill Afonin
Kirill Afonin

20 January 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JHJustin R. Halman
Justin R. Halman
ESEmily Satterwhite
Emily Satterwhite
BRBrandon Roark
Brandon Roark
MCMorgan Chandler
Morgan Chandler
MVMathias Viard
Mathias Viard
KAKirill Afonin
Kirill Afonin
We introduce a new concept that utilizes cognate nucleic acid nanoparticles which are fully complementary and functionally-interdependent to each other. In the described approach, the physical interaction between sets of designed nanoparticles initiates a rapid isothermal shape change which triggers the activation of multiple functionalities and biological pathways including transcription, energy transfer, functional aptamers and RNA interference. The individual nanoparticles are not active and have controllable kinetics of re-association and fine-tunable chemical and thermodynamic stabilities. Computational algorithms were developed to accurately predict melting temperatures of nanoparticles of various compositions and trace the process of their re-association in silico. Additionally, tunable immunostimulatory properties of described nanoparticles suggest that the particles that do not induce pro-inflammatory cytokines and high levels of interferons can be used as scaffolds to carry therapeutic oligonucleotides, while particles with strong interferon and mild pro-inflammatory cytokine induction may qualify as vaccine adjuvants. The presented concept provides a simple, cost-effective and straightforward model for the development of combinatorial regulation of biological processes in nucleic acid nanotechnology.

20 April 2021 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
MJM. Brittany Johnson
M. Brittany Johnson
MCMorgan Chandler
Morgan Chandler
KAKirill Afonin
Kirill Afonin

1 January 2020 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
JHJustin R. Halman
Justin R. Halman
KKKi-Taek Kim
Ki-Taek Kim
SGSo-Jung Gwak
So-Jung Gwak
RPRichard Pace
Richard Pace
MJM. Brittany Johnson
M. Brittany Johnson
KAKirill Afonin
Kirill Afonin

25 November 2019 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
MCMorgan Chandler
Morgan Chandler
MJMorgan Brittany Johnson
Morgan Brittany Johnson
MPMartin Panigaj
Martin Panigaj
KAKirill Afonin
Kirill Afonin

18 August 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
RJRidhima Juneja
Ridhima Juneja
HVHemapriyadarshini Vadarevu
Hemapriyadarshini Vadarevu
JHJustin Halman
Justin Halman
MTMubin Tarannum
Mubin Tarannum
LRLauren Rackley
Lauren Rackley
JVJuan Vivero-Escoto
Juan Vivero-Escoto